• Address4000 Shoreline Ct, Suite 200, South San Francisco, California 94080, US
  • Websitetrishulatx.com
  • InvestorsCanaan Partners

About Trishula Therapeutics

A clinical-stage cancer immunotherapy company developing TTX-030, a first-in-class anti-CD39 antibody.

Jobs From Trishula Therapeutics

No Jobs found with this criteria